Nuvei, which is backed by private equity firms Advent International and Novacap alongside investor CDPQ, is in advanced discussions to acquire cross-border payments provider Payoneer in a deal valued at around $2.7bn, according to a report by Reuters.
Private equity firm PAI Partners has followed KKR in withdrawing from the bidding process for a potential 50% stake in Nestlé’s water business, which includes brands such as Perrier, according to a report by Bloomberg.
Bain Capital has entered the auction process for Australian outdoor advertising firm oOh!media, joining a growing group of private equity bidders competing for the business, according to a report by the Australian Financial Review.
Private equity technology deal activity has fallen sharply as artificial intelligence reshapes valuation expectations and increases uncertainty around software business models, according to report by Bloomberg citing Bain & Company analysis of Dealogic data.
Global alternative asset manager The Carlyle Group has signed a definitive agreement to acquire up to 100% of South Korea-based Chung Ho Group, a leading provider of subscription-based home and healthcare appliance rental services, for a reported $700m.
Private investment major Apollo Global Management has abandoned its proposed £1.5bn takeover of London-listed Bodycote plc, marking another setback in the firm’s efforts to acquire listed UK industrial assets, according to a report by the Financial Times.
TOP STORY: New York-based fund administration group Gen II Fund Services, which is backed by Hg and General Atlantic, is exploring a potential sale that could value the business at up to $6bn, according to a report by the Financial Times citing unnamed market sources.
Private equity investment in software companies has fallen sharply in 2026, hitting its weakest level since the Covid-19 pandemic, as concerns over AI reshape expectations for the sector’s long-term earnings power and business models, according to a report by the Financial Times citing data from PitchBook.
Oxford BioMedica has indicated it could consider a private equity takeover under the right circumstances, even after rejecting multiple unsolicited approaches from Sweden’s EQT earlier this year, according to a report by the Financial Times citing comments from its chief executive.
LaserAway, a US medspa and aesthetic dermatology operator backed by Ares Management and Seidler Equity Partners, is exploring a potential sale that could value the business at more than $2bn, according to a report by Reuters citing unnamed people familiar with the situation.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
